ArticleDiabetes & metabolism journal2026
Abnormally Elevated PKCδ Delays Diabetic Wound Healing by Inhibiting the GAD1-GABA Pathway.
Article in Diabetes & metabolism journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgruoundDiabetic foot ulcer (DFU) is a challenging complication of diabetes mellitus, characterized by delayed wound healing. Protein kinase C delta (PKCδ) has been identified as an important factor in the pathogenesis of various diabetic complications, including DFU. However, the precise underlying mechanisms remain incompletely elucidated.
methodsHuman umbilical vein endothelial cells (HUVECs) were cultured under high-glucose conditions, and PKCδ was knocked down using siRNA. The proliferation, migration, and tube formation of HUVECs were assessed. Metabolomic sequencing was performed to identify potential metabolites contributing to these changes. HUVEC proliferation, migration, tube formation, and apoptosis were then assessed after regulation of the selected metabolite. Finally, the effect of the metabolite on diabetic wound healing was evaluated.
resultsIn vitro, PKCδ knockdown upregulated glutamate decarboxylase 1 (GAD1) expression and gamma-aminobutyric acid (GABA) levels, which enhanced proliferation, migration, and tube formation and suppressed apoptosis of HUVECs under high glucose conditions. Interestingly, inhibition of GAD1 in normal glucose-treated HUVECs decreased proliferation, migration, and tube formation, and increased apoptosis. Furthermore, in vivo experiments demonstrated that topical administration of GABA accelerated the healing of diabetic wounds in streptozotocin-induced type 2 diabetes mellitus mice, as manifested by increased angiogenesis and proliferation.
conclusionPKCδ-mediated inhibition of the GAD1-GABA pathway suppresses endothelial cell proliferation, migration, and tube formation and promotes apoptosis under high-glucose conditions, thereby delaying diabetic wound healing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.